Research graph
References from Severe anaphylactic shock suspectedly induced by injection of recombinant humanized type III collagen lyophilized fiber for facial skin improvement: a case report. Local targets link to admitted publications; unresolved targets remain external evidence.
Expert consensus on the operation specifications of collagen periorbital filling
2022 · External reference
Operation specification of recombinant type Ⅲ humanized collagen injection technology
2023 · External reference
Complications and litigation associated with injectable facial fillers: a cross-sectional study
10.1016/j.joms.2019.08.003 · 2020 · External reference
An experimental study of the vascular embolism caused by recombinant type III collagen implants and hyaluronic acid
10.1111/jocd.15769 · 2023 · External reference
Electrospun nanofibrous membranes of recombinant human collagen type III promote cutaneous wound healing
10.1039/d3tb00438d · 2023 · External reference
Utility of food allergy thresholds
10.1016/j.anai.2023.12.012 · 2024 · External reference
Anaphylaxis: a 2023 practice parameter update
10.1016/j.anai.2023.09.015 · 2024 · External reference
World allergy organization anaphylaxis guidance 2020
10.1016/j.waojou.2020.100472 · 2020 · External reference
Anaphylactic reactions to local anesthetics: a review of the literature from 1950 to 2011 and presentation of 54 cases
2013 · External reference
Evaluation of adverse reactions to local anesthetics:experience with 236 patients
10.1016/s1081-1206(10)61680-8 · 2003 · External reference
Idiopathic anaphylaxis
10.1016/j.jaip.2025.08.019 · 2025 · External reference
Local anesthetic systemic toxicity
10.1007/s12630-010-9275-7 · 2010 · External reference
The diagnosis and management of anaphylaxis practice parameter: 2010 update
10.1016/j.jaci.2010.06.022 · 2010 · External reference
Molecular mechanisms and pathophysiology of perioperative hypersensitivity and anaphylaxis: a narrative review
10.1016/j.bja.2019.01.031 · 2019 · External reference
2015 Update of the evidence base: world allergy organization anaphylaxis guidelines
10.1186/s40413-015-0080-1 · 2015 · External reference
Anaphylaxis—a 2020 practice parameter update, systematic review, and grading of recommendations, assessment, development and evaluation (GRADE) analysis
10.1016/j.jaci.2020.01.017 · 2020 · External reference
Anaphylaxis: emergency department treatment
10.1016/j.emc.2021.08.004 · 2022 · External reference
Emergency treatment of anaphylaxis: concise clinical guidance
10.7861/clinmed.2022-0073 · 2022 · External reference
Benefits of epinephrine for anaphylaxis outweigh potential harm—a safety review
10.1016/j.jaip.2025.04.018 · 2025 · External reference
Management of refractory anaphylaxis: an overview of current guidelines
10.1111/cea.14514 · 2024 · External reference
The 10-point plan 2021: updated concepts for improved procedural safety during facial filler treatments
10.2147/ccid.s315711 · 2021 · External reference
ASDS Guidelines of care: injectable fillers
10.1111/j.1524-4725.2008.34253.x · 2008 · External reference
Hypersensitivity reaction to hyaluronic acid dermal filler following novel coronavirus infection - a case report
10.1111/jocd.14074 · 2021 · External reference
Facial aesthetic injections in clinical practice: pretreatment and posttreatment consensus recommendations to minimise adverse outcomes
10.1111/ajd.13273 · 2020 · External reference
